Research: FDA drug labels not proof of patent violation
Medical Xpress
February 16, 2026
Federal law requires every prescription drug to include a document describing dosing guidelines, contraindications, results from clinical trials and safety considerations. But a spate of recent court decisions has problematically treated that safety information in a drug's legally required package insert as key evidence in high-stakes patent cases against generic-drug manufacturers.
Verticals
healthmedical
Originally published on Medical Xpress on 2/16/2026